Developing innovative new medical products to protect the health of people in our community.
Tegsal is developing a dynamic new multimodal wound dressing. This polymeric wound dressing will give first responders a powerful tool to control urgent bleeds, prevent infections and aid the healing process, all in one intuitive application.
Revolutionizing Infection Prevention
The Current Challenge in Wound Care
60,000
Every year, traumatic hemorrhage claims the lives of over 60,000 Americans, with many of these fatalities deemed preventable.
11 Million
Shockingly, more than 11 million individuals seek emergency room care for traumatic lacerations, often resulting in severe infections that elevate the risks of illness and death.
The healthcare landscape lacks a comprehensive solution that addresses these critical challenges in a single, simple step.
Our potential for widespread adoption can reshape patient care and save lives on a grand scale.
Technology Overview
Tegsal is developing a multi-modal wound dressing effective in controlling bleeding and preventing infection. Currently, we are refining the polymer platform technology and are achieving exciting results in pre-clinical bactericidal and hemostatic testing.
Caution: Investigational Device. Limited by United States Law to investigational use.
CAUTION. PolyTeg device investigational. Limited by United States Law to Investigational Use.
PolyTeg™ is trademark of Tegsal, Inc. This site is protected by United States and international copyright and trademark laws. The contents of the Site may not be distributed, modified, reproduced, or used, in whole or in part, without the prior written consent of Tegsal. Any copies of material or other content provided through the Site must include the same copyright and other proprietary notices that appear with the material or content.
